Coherus Oncology (CHRS) Cash from Investing Activities (2013 - 2026)
Coherus Oncology (CHRS) posted Cash from Investing Activities of $29.63 million for Q2 2026, down 93.6% from $462.64 million a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Cash from Investing Activities (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at Coherus Oncology was -$9.78 million; for FY2025, it was $375.09 million, up 62.9% from FY2024.
- In prior years, Coherus Oncology's Cash from Investing Activities was $230.32 million in FY2024 (+59.2%), $144.64 million in FY2023, -$166.85 million in FY2022 and -$138.41 million in FY2021.
- Quarterly Cash from Investing Activities has run from a low of -$129.9 million in Q4 2022 to a high of $462.64 million in Q2 2025 over five years.
- According to Business Quant data, Cash from Investing Activities for the three prior quarters was $30.66 million (Q1 2026), -$2.84 million (Q4 2025) and -$67.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 29.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.63 Mn |
| Mar 31, 2026 | 30.66 Mn |
| Dec 31, 2025 | -2.84 Mn |
| Sep 30, 2025 | -67.23 Mn |
| Jun 30, 2025 | 462.64 Mn |
| Mar 31, 2025 | -17.49 Mn |
| Dec 31, 2024 | -542,000.00 |
| Sep 30, 2024 | 444,000.00 |
| Jun 30, 2024 | 27.66 Mn |
| Mar 31, 2024 | 202.76 Mn |
| Dec 31, 2023 | 35.20 Mn |
| Sep 30, 2023 | 50.55 Mn |
| Jun 30, 2023 | 41.37 Mn |
| Mar 31, 2023 | 17.53 Mn |
| Dec 31, 2022 | -129.90 Mn |
| Sep 30, 2022 | -457,000.00 |
| Jun 30, 2022 | -880,000.00 |
| Mar 31, 2022 | -35.62 Mn |
| Dec 31, 2021 | 107.49 Mn |
| Sep 30, 2021 | 15.99 Mn |
API Access
Coherus Oncology Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();